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Abstract
Background: The association between -250G>A polymorphism in the promoter region of the hepatic lipase gene
(LIPC) and plasma high-density lipoprotein cholesterol (HDL-C) concentration is contradictory in diverse ethnics. Bai
Ku Yao is an isolated subgroup of the Yao minority in China. This study was designed to detect the association of
LIPC -250G>A (rs2070895) polymorphism and several environmental factors with serum lipid levels in the Guangxi
Bai Ku Yao and Han populations.
Methods: A total of 778 subjects of Bai Ku Yao and 648 participants of Han Chinese aged 15-80 were randomly
selected from our previous stratified randomized cluster samples. Genotyping of the LIPC -250G>A was performed
by polymerse chain reaction and restriction fragment length polymorphism combined with gel electrophoresis,
and then confirmed by direct sequencing.
Results: The levels of serum total cholesterol (TC), HDL-C, low-density lipoprotein cholesterol (LDL-C) and
apolipoprotein (Apo) AI were lower in Bai Ku Yao than in Han (P < 0.01 for all). The frequencies of GG, GA and AA
genotypes were 50.0%, 43.3% and 6.7% in Bai Ku Yao, and 35.7%, 50.6% and 13.7% in Han (P < 0.01); respectively.
The frequencies of G and A alleles were 71.7% and 28.3% in Bai Ku Yao, and 61.0% and 39.0% in Han (P < 0.01).
The levels of HDL-C and the ratio of ApoAI to ApoB in Bai Ku Yao were lower in GG genotype than in GA or AA
genotype (P < 0.05-0.01). The levels of TC, HDL-C, LDL-C and ApoB in Han were lower in GG genotype than in GA
or AA genotype (P < 0.05-0.01). The levels of HDL-C and the ratio of ApoAI to ApoB in Bai Ku Yao, and the levels
of HDL-C, LDL-C and ApoB in Han were correlated with genotype and/or allele (P < 0.05 for all). Serum lipid
parameters were also correlated with age, sex, alcohol consumption, cigarette smoking, blood pressure, body
weight, and body mass index in both ethnic groups.
Conclusions: The differences in the serum lipid profiles between the two ethnic groups might partly result from
different genotypic frequency of LIPC -250G>A or different LIPC-enviromental interactions.
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Coronary artery disease is the most common cause of
morbidity and mortality in the industrialized nations
and is of growing concern in developing countries. Epi-
demiological studies have shown that dyslipidaemia,
including high levels of plasma or serum total choles-
terol (TC) [1,2], triglycerides (TGs) [3,4], low-density
lipoprotein cholesterol (LDL-C) [5,6] and apolipoprotein
B (ApoB) [7,8], and low levels of high-density lipopro-
tein cholesterol (HDL-C) [9,10], is a risk factor for the
progression of atherosclerosis and the development of
coronary artery disease. It is well known that plasma
lipid concentrations are modulated by both environmen-
tal factors such as demographics [11], diet [12], alcohol
consumption [13], cigarette smoking [13,14], obesity
[15], exercise [16], hypertension [17] as well as genetic
factors. Family and twin studies have shown that genetic
polymorphism could account for 40-80% of the interin-
dividual variation in plasma lipid concentrations [18-20].
Hepatic lipase is an enzyme that regulates the metabo-
lism of low-density lipoprotein (LDL), intermediate-den-
sity lipoprotein (IDL), and HDL particles [21,22]. High
hepatic lipase activity is associated with low HDL-C
level, and hepatic lipase converts large, TG-rich HDL2-C
into small, dense HDL3-C [23]. Hepatic lipase also cata-
lyzes the hydrolysis of TG and phospholipids in large,
buoyant LDL to form more atherogenic small, dense
LDL particles [24,25]. Hepatic lipase activity is deter-
mined by gender, visceral obesity, insulin resistance,
diet, and genotype. Approximately 20-30% of the indivi-
dual variation in hepatic lipase activity is due to the pre-
sence of a common polymorphism in the promoter
region of the hepatic lipase gene [26]. The human hepa-
tic lipase gene (LIPC), located on chromosome 15q21, is
comprised of nine exons and eight introns, spans over
30 kb of DNA, and encodes a protein of 449 amino
acids [27,28]. LIPC variants have been found to affect
lipase activity. Four different promoter polymorphisms
of the LIPC have been identified (-250G>A, -514C>T,
-710T>C, and -763A>G), which are in complete linkage
disequilibrium [29,30]. The -250G>A substitution in the
promoter region of the LIPC has been found to be asso-
ciated with modifications of plasma lipid concentrations
[31-38] and the risk of coronary artery disease [39,40] in
some studies but not in others [41-44].
There are fifty-six ethnic groups in China. Han is the
largest group and Yao is the eleventh largest minority
among the 55 minority groups according to the popula-
tion size. Bai Ku Yao (White-trouser Yao), an isolated
subgroup of the Yao minority, is named so because all
the men wear white knee-length knickerbockers. The
population size is about 30000. Because of isolation
from the other ethnic groups, the special customs and
cultures including their clothing, intra-ethnic marriages,
dietary habits, and corn wine and rum intakes are still
completely preserved to the present day. In a previous
epidemiologic study, we found that the serum lipid con-
centrations were lower in Bai Ku Yao than in Han Chi-
nese from the same region [45]. This ethnic difference
in serum lipid concentrations is still not well known.
We hypothesized that there may be significant differ-
ences in some genetic polymorphisms between the two
ethnic groups. Therefore, the aim of the present study
was to detect the association of LIPC -250G>A
(rs2070895) polymorphism and several environmental
factors with serum lipid levels in the Guangxi Bai Ku
Yao and Han populations.
Materials and methods
Study population
A total of 778 subjects of Bai Ku Yao who reside in Lihu
and Baxu villages in Nandan County, Guangxi Zhuang
Autonomous Region, People’sR e p u b l i co fC h i n aw e r e
randomly selected from our previous stratified rando-
mized cluster samples [45]. The ages of the subjects ran-
ged from 15 to 80 years, with an average age of 40.28 ±
13.78 years. There were 405 males (52.1%) and 373
females (47.9%). All subjects were peasants. The subjects
accounted for 2.59% of total Bai Ku Yao population.
D u r i n gt h es a m ep e r i o d ,at o t a lo f6 4 8p e o p l eo fH a n
Chinese who reside in the same villages were also ran-
domly selected from our previous stratified randomized
cluster samples [45]. The mean age of the subjects was
40.22 ± 15.52 years (range 15 to 80). There were 315
men (48.6%) and 333 women (51.4%). All of them were
also peasants. All study subjects were essentially healthy
and had no evidence of any chronic illness, including
hepatic, renal, or thyroid. The participants with a history
of heart attack or myocardial infarction, stroke, conges-
tive heart failure, diabetes or fasting blood glucose ≥ 7.0
mmol/L determined by glucose meter were also rejected.
The participants were not taking medications known to
affect serum lipid levels (lipid-lowering drugs such as
statins or fibrates, beta-blockers, diuretics, or hor-
mones). The present study was approved by the Ethics
Committee of the First Affiliated Hospital, Guangxi
Medical University. Informed consent was obtained
from all subjects after they received a full explanation of
the study.
Epidemiological survey
The survey was carried out using internationally stan-
dardized methods, following a common protocol [46].
I n f o r m a t i o no nd e m o g r a p h i c s, socioeconomic status,
and lifestyle factors was collected with standardized
questionnaires. Overall physical activity was ascertained
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Alumni Physical Activity Questionnaire [47], which
included questions about the number of hours per day
(mean of a regular weekday and a regular weekend day)
spent sleeping and in sedentary, light, moderate, and
vigorous activities; the interviewer ensured that the total
time added up to 24 h. The alcohol information
included questions about the number of liangs (about
50 g) of rice wine, corn wine, rum, beer, or liquor con-
sumed during the preceding1 2m o n t h s .A l c o h o lc o n -
sumption was categorized into groups of grams of
alcohol per day: ≤ 25 and ≥ 25. Smoking status was
categorized into groups of cigarettes per day: ≤ 20 and ≥
20. At the physical examination, several anthropometric
parameters, such as height, weight, and waist circumfer-
ence were measured. Sitting blood pressure was mea-
sured three times with the use of a mercury
sphygmomanometer after an at least 15-min rest, and
the average of the three measurements was used for the
level of blood pressure. Systolic blood pressure was
determined by the first Korotkoff sound, and diastolic
blood pressure by the fifth Korotkoff sound. Body
weight, to the nearest 50 grams, was measured using a
portable balance scale. Subjects were weighed without
shoes and in a minimum of clothing. Height was mea-
sured, to the nearest 0.5 cm, using a portable steel mea-
suring device. From these two measurements body mass
index (BMI, kg/m
2) was calculated. Waist circumference
was measured with a nonstretchable measuring tape, at
the level of the smallest area of the waist, to the nearest
0.1 cm.
Biochemical analysis
A venous blood sample of 8 ml was obtained from all
subjects between 8 and 11 AM, after at least 12 hours
of fasting, from a forearm vein after venous occlusion
for few seconds in a sitting position. 3 ml was collected
into glass tubes and allowed to clot at room tempera-
ture, and used to determine serum lipid levels, and the
remaining 5 ml was transferred to tubes with anticoagu-
late solution (4.80 g/L citric acid, 14.70 g/L glucose, and
13.20 g/L tri-sodium citrate) and used to extract DNA.
Immediately following clotting serum was separated by
centrifugation for 15 minutes at 3000 rpm. The levels of
TC, TG, HDL-C, and LDL-C in samples were deter-
mined by enzymatic methods with commercially avail-
able kits, Tcho-1, TG-LH (RANDOX Laboratories Ltd.,
Ardmore, Diamond Road, Crumlin Co. Antrim, United
Kingdom, BT29 4QY), Cholestest N HDL, and Cholest-
est LDL (Daiichi Pure Chemicals Co., Ltd., Tokyo,
Japan), respectively. Serum ApoAI and ApoB levels were
detected by the immunoturbidimetric immunoassay
using a commercial kit (RANDOX Laboratories Ltd.).
All determinations were performed with an autoanalyzer
(Type 7170A; Hitachi Ltd., Tokyo, Japan) in the Clinical
Science Experiment Center of the First Affiliated Hospi-
tal, Guangxi Medical University [45,48].
DNA amplification and genotyping
Genomic DNA was isolated from peripheral blood leu-
kocytes using the phenol-chloroform method [17]. The
extracted DNA was stored at 4°C until analysis. Geno-
typing of the LIPC -250G>A was performed by polymer-
ase chain reaction and restriction fragment length
polymorphism (PCR-RFLP). PCR amplification was per-
formed using 5’-GGCAAGGGCATCTTTGCTTC-3’ and
5’-GGTCGATTTACAGAAGTGCTTC-3’ (Sangon,
Shanghai, China) as the forward and reverse primer
pairs, respectively. Each amplification reaction was per-
formed in a total volume of 25 mL, containing 10 ×
PCR buffer (1.8 mM MgCl2)2 . 5μL, 1 U Taq polymer-
ase, 2.5 mmol/L of each dNTP (Tiangen, Beijing,
China) 2.0 μL, 20 pmol/L of each primer and 50 ng of
genomic DNA, processing started with 94°C for 5 min
and 30 cycles at 94°C for 30 s, 58.8°C for 30 s and 72°
C for 30 s. This was followed by a final extension at
7 2 ° Cf o r4m i n .T h e n1 0Uo fDraI enzyme was added
directly to the PCR products (10 μL) and digested at
37°C overnight. 3 μL of the digestive products were
loaded on 12% polyacrylamide ready gels and then
were separated by electrophoresis for 25 min at 300
mV. The gel was stained with silver nitrate cream
(0.15%) for 15 min, and then added 100 ml of NaOH
(1.5%) and 2.2 ml of formaldehyde after pour off the
silver nitrate cream, jolted slowly untill the gel was
visualized. The digestive products can be directly
observed. Genotypes were scored by an experienced
reader blinded to epidemiological and lipid results. Six
samples (GG, GA and AA genotypes in two, respec-
tively) detected by the PCR-RFLP were also confirmed
by direct sequencing. The PCR product was purified
by low melting point gel electrophoresis and phenol
extraction, and then the DNA sequence were analyzed
in Shanghai Sangon Biological Engineering Technology
& Services Co., Ltd., China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI, ApoB, and the ratio of ApoAI to ApoB in our
Clinical Science Experiment Center were 3.10-5.17,
0.56-1.70, 0.91-1.81, 2.70-3.20 mmol/L, 1.00-1.78, 0.63-
1.14 g/L, and 1.00-2.50, respectively. The individuals
with TC > 5.17 mmol/L and/or TG > 1.70 mmol/L were
defined as hyperlipidemic [45,48]. Hypertension was
diagnosed according to the criteria of 1999 World
Health Organization-International Society of Hyperten-
sion Guidelines for the management of hypertension
[49,50]. The diagnostic criteria of overweight and obesity
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of China Obesity Task Force. Normal weight, over-
weight and obesity were defined as a BMI < 24, 24-28,
and >28 kg/m
2, respectively [45,48-50].
Statistical analyses
Epidemiological data were recorded on a pre-designed
form and managed with Excel software. All statistical
analyses were done with the statistical software package
SPSS 11.5 (SPSS Inc., Chicago, Illinois). Quantitative
variables were expressed as mean ± standard deviation
(SD), and qualitative variables as percentages. Allele fre-
quency was determined via direct counting, and the
standard goodness-of-fit test was used to test the
Hardy-Weinberg equilibrium. Differences in genotype
distribution between the groups were obtained using the
chi-square test. The difference in general characteristics
between Bai Ku Yao and Han was tested by the Stu-
dent’s unpaired t-test. The association of genotypes with
lipid variables was tested by analysis of covariance
( A N C O V A ) .S e x ,a g e ,B M I ,b l o o dp r e s s u r e ,a l c o h o l
intake, cigarette smoking were adjusted for the statistical
analysis. In order to evaluate the association of serum
lipid levels with genotypes and several environment fac-
tors, multivariate logistic regression analysis was also
performed. A P value of less than 0.05 was considered
statistically significant.
Results
General characteristics and serum lipid levels
Table 1 gives the general characteristics between the Bai
Ku Yao and Han populations. The levels of systolic
blood pressure, pulse pressure, serum TC, HDL-C,
LDL-C, ApoAI and the ratio of ApoAI to ApoB were
l o w e ri nB a iK uY a ot h a ni nH a n( P <0 . 0 1f o ra l l ) ,
whereas physical activity, BMI and the percentages of
subjects who smoked cigarettes were higher in Bai Ku
Yao than in Han (P < 0.01 for each). There were no sig-
nificant differences in diastolic blood pressure, TG,
ApoB levels, age structure, the percentages of subjects
who consumed alcohol, or the ratio of male to female
between the two ethnic groups (P > 0.05).
Results of electrophoresis and genotyping
After the genomic DNA of the samples was amplified by
PCR and imaged by 2% agarose gel electrophoresis, the
purpose gene of 411-bp nucleotide sequences could be
found in all samples (Figure 1). The genotypes identified
were named according to the presence or absence of the
enzyme restriction sites, when a G to A transversion at
Table 1 The general characteristics and serum lipid levels between the Bai Ku Yao and Han populations
Parameter Bai Ku Yao Han Chinese t(c
2) P
Number 778 648
Male/female 405/373 315/333 -1.519 0.129
Age (years) 40.28 ± 13.78 40.22 ± 15.52 -1.850 0.065
Body mass index (kg/m
2) 22.31 ± 2.86 21.69 ± 2.84 4.166 0.000
Physical activity (h/week) 46.71 ± 12.78 43.56 ± 11.96 4.771 0.000
Systolic blood pressure (mmHg) 116.30 ± 15.62 119 ± 17.55 -3.757 0.000
Diastolic blood pressure (mmHg) 74.66 ± 9.17 74.82 ± 10.80 -0.286 0.775
Pulse pressure (mmHg) 41.63 ± 11.54 44.81 ± 12.19 -5.028 0.000
Cigarette smoking [n(%)]
Nonsmoker 526(67.6) 518(79.9)
≤20 cigarettes/day 136(17.5) 30(4.6)
>20 cigarettes/day 116(14.9) 100(15.4) 57.560 0.000
Alcohol consumption [n(%)]
Nondrinker 487(62.6) 398(61.4)
≤25 g/day 197(25.3) 174(26.9)
>25 g/day 94(12.1) 76(11.7) 0.434 0.805
Total cholesterol (mmol/L) 4.27 ± 0.92 4.63 ± 1.00 -7.010 0.000
Triglycerides (mmol/L) 1.28 ± 1.11 1.25 ± 0.98 0.531 0.596
HDL-C (mmol/L) 1.64 ± 0.42 1.79 ± 0.50 -6.292 0.000
LDL-C (mmol/L) 2.51 ± 0.75 2.72 ± 0.80 -5.147 0.000
Apolipoprotein (Apo) AI (g/L) 1.29 ± 0.33 1.40 ± 0.36 -6.092 0.000
ApoB (g/L) 0.83 ± 0.22 0.82 ± 0.21 0.541 0.588
ApoAI/ApoB 1.68 ± 0.79 1.79 ± 0.62 -2.814 0.005
HDL-C, highdensity lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
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cutting site indicates the -250A allele, while its absence
indicates the -250G allele. Thus, the GG genotype is
homozygote for the absence of the site (band at 411 bp),
GA genotype is heterozygote for the presence and
absence of the site (bands at 411-, 301- and 110-bp),
and AA genotype is homozygote for the presence of the
site (bands at 301- and 110- bp; Figure 2).
Genotypic and allelic frequencies
The frequencies of the LIPC -250G>A alleles and geno-
types are shown in Table 2. The frequencies of G and A
alleles were 71.7% and 28.3% in Bai Ku Yao, and 61.0%
and 39.0% in Han (P < 0.01). The frequencies of GG,
GA and AA genotypes were 50.0%, 43.3% and 6.7% in
Bai Ku Yao, and 35.7%, 50.6% and 13.7% in Han (P <
0.01); respectively.
Figure 1 Electrophoresis of PCR products of the samples.L a n eM ,1 0 0 - b pm a r k e rl a d d e r ;l a n e s1 –8, samples. The 411-bp bands are the
target genes.
Figure 2 Genotyping of PCR products of the samples. Lane M, 100 bp Marker Ladder; Lanes 1-3, GG genotype (411 bp); Lane 4, GA
genotype (411 bp, 301 bp and 110 bp); and lanes 5-7, AA genotype (301 bp and 110 bp)
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The results shown as GG, GA and AA genotypes by
PCR-RFLP, GG, GA and AA genotypes were also con-
firmed by sequencing (Figure 3).
Genotypes and serum lipid levels
As shown in Table 3, the levels of HDL-C and the ratio
of ApoAI to ApoB were significant differences among
the three genotypes in the Bai Ku Yao population (P <
0.01 for each). There were also significant differences in
the levels of TC, HDL-C, LDL-C and ApoB among the
three genotypes in the Han population (P < 0.05-0.001)
after adjustment for all the covariates. There were no
significant differences in the levels of TG and ApoAI
among the three genotypes in the both ethnic groups
(P > 0.05).
Risk factors for the lipid parameters
Multivariate logistic regression analysis showed that the
levels of HDL-C and the ratio of ApoAI to ApoB were
correlated with genotype in the Bai Ku Yao population (P
< 0.01 for each), whereas the levels of HDL-C, LDL-C
and ApoB were correlated with genotype and/or allele in
the Han population (P < 0.05-0.01). The lipid parameters
were also found to correlate with gender, age, BMI, alco-
hol consumption, cigarette smoking, blood pressure, and
physical activity in the both ethnic groups (Table 4).
Discussion
The present study shows that the serum levels of TC,
HDL-C, LDL-C, ApoAI and the ratio of ApoAI to ApoB
were lower in Bai Ku Yao than in Han. There were no
significant differences in serum TG and ApoB levels
between the two ethnic groups. These findings are con-
sistent with those of our previous studies in a large
population [45]. It is well known that dyslipidaemia is a
complex trait caused by multiple environmental and
genetic factors and their interactions. Bai Ku Yao is an
isolated subgroups of the Yao minority in China. Strict
intra-ethnic marriages have been performed in this
population from time immemorial. Therefore, we
hypothesized that the hereditary characteristic and geno-
types of some lipid metabolism-related genes in this
population may be different from those in Han Chinese.
The frequency of the less common haplotype was
found to range between 0.15 to 0.21 among Caucasians
[41], 0.32 among Brazilian [39], 0.39 among Taiwa-
nese-Chinese [33], 0.45-0.53 among African Americans
[41,51] and 0.47 among Japanese-Americans [41]. The
allele frequencies between white and black subjects are
quite different: the less common allele of the LIPC
polymorphisms in white subjects was the more com-
mon allele in black subjects [41,51]. In the present
study, we show that the frequency of the LIPC -250G
allele was higher in Bai Ku Yao than in Han. The fre-
quency of GG genotype was also higher in Bai Ku Yao
than in Han. The frequencies of the LIPC -250G allele
and GG genotype in the Bai Ku Yao and Han popula-
tions were also higher than those of previous studies
in Caucasians [51,52], These results indicate that the
allelic variation of the LIPC -250G>A may have an eth-
nic specificity.
The potential relationship between the LIPC -250G>A
polymorphism and plasma or serum lipid levels in
humans has been evaluated in a large number of studies.
However, previous findings on the association of this
polymorphism with the changes in plasma lipid levels
are inconsistent. Several studies have reported signifi-
cant association between the LIPC -250G>A polymorph-
isms and HDL-C levels [32-35,38], whereas several
reports failed to find a significant genetic effect on
HDL-C concentrations [41-44]. Zambon et al [41]
found that the promoter polymorphism significantly
influenced HDL2-C but not HDL-C levels. In the pre-
sent study, we found that the -250A carriers were asso-
ciated with high HDL-C levels and the ratio of ApoAI
t oA p o Bi nB a iK uY a o ,a n dh i g hT C ,H D L - C ,L D L - C
and ApoB concentration in Han. The reason for this
discrepancy between the two ethnic groups is currently
unknown. In a previous studies, Lindi et al [34] found
that the -250AA genotype was associated with high
serum LDL-C concentration, and that the monounsatu-
rated fatty acids-enriched diet reduced serum LDL-C
concentration especially in subjects with the -250AA
genotype. The impact of n-3 fatty acids on lipid and glu-
cose metabolism did not differ among genotypes of the
-250G>A polymorphism. Hepatic lipase also contributes
to hepatic uptake of ApoB-containing lipoproteins [53].
Thus, it can be speculated that LDL catabolism may be
marginally disturbed in subjects with the -250AA geno-
type compared to those with other genotypes and this
could lead to slightly increased serum LDL-C concentra-
tions. In another study, Deeb et al [54] have shown, by
transient transfection assays of the murine hepatocyte
cell line AML12, that the -514T allele of the LIPC pro-
moter has approximately 30% lower activity than the C
allele. But the -250G>A polymorphism does not seem to
have any impact on promoter activity in this transient
Table 2 Genotypic and allelic frequencies between the
Bai Ku Yao and Han populations [n(%)]
Group Genotype Allele
nG G G A A A G A
Bai Ku Yao 778 389 (50.0) 337 (43.3) 52 (6.7) 115(71.7) 441(28.3)
Han Chinese 648 231(35.7) 328 (50.6) 89 (13.7) 790(61.0) 506(39.0)
c
2 - 38.565 36.598
P - 0.000 0.000
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Page 6 of 11Figure 3 A part of the nucleotide sequence in the LIPC –250G>A locus. (A) GG genotype; (B) GA genotype; (C) AA genotype
Table 3 The LIPC –250G>A genotypes and serum lipid levels between the Bai Ku Yao and Han populations
Group Genotype n TC
(mmol/L)
TG
(mmol/L)
HDL-C
(mmol/L)
LDL-C
(mmol/L)
ApoAI
(g/L)
ApoB
(g/L)
ApoAI/ApoB
Bai Ku Yao GG 389 4.23 ± 0.79 1.26 ± 1.11 1.59 ± 0.42 2.48 ± 0.64 1.28 ± 0.32 0.82 ± 0.21 1.62 ± 0.72
GA 337 4.32 ± 1.06 1.25 ± 1.09 1.67 ± .41
b 2.56 ± 0.86 1.27 ± 0.33 0.84 ± 0.23 1.70 ± 0.81
AA 52 4.27 ± 0.86 1.58 ± 1.22 1.75 ± 0.44
a 2.36 ± 0.71 1.40 ± 0.38 0.79 ± 0.23 1.98 ± 1.02
bc
F - - 0.380 1.371 5.427 1.464 1.982 1.526 5.073
P - - 0.684 0.254 0.005 0.232 0.139 0.218 0.007
Han Chinese GG 231 4.39 ± 0.79 1.20 ± 0.80 1.77 ± 0.50 2.52 ± 0.56 1.40 ± 0.35 0.76 ± 0.16 1.76 ± 0.62
GA 328 4.65 ± 1.06
b 1.17 ± 1.20 1.82 ± 0.51 2.73 ± 0.86
b 1.40 ± 0.36 0.83 ± 0.22
b 1.79 ± 0.64
AA 89 4.69 ± 0.96
a 1.30 ± 1.02 1.93 ± 0.48
a 2.77 ± 0.79
a 1.39 ± 0.36 0.84 ± 0.21
b 1.87 ± 0.51
F - - 5.901 1.017 3.267 6.304 1.800 9.834 1.023
P - - 0.003 0.362 0.039 0.002 0.166 0.001 0.360
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B; ApoAI/ApoB, the ratio of apolipoprotein AI to apolipoprotein B;
aP < 0.05 and
bP < 0.01 in comparison with GG genotype of same ethnic group;
cP < 0.05 in comparison with GA genotype of same ethnic group.
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colleagues [30] found that 38% of the variation of the
hepatic lipase activity was associated with the LIPC pro-
moter haplotypes, but only 25% of variation in HDL-C
is associated with hepatic lipase activity. Thus, with
many other factors affecting HDL-C levels, one would
not expect to observe significant associations between
HDL-C and the LIPC promoter haplotypes in all studies.
Tahvanainen et al [42] have shown that carriers of the
A allele have significantly higher amounts of TG in IDL,
LDL, and HDL particles, making them more buoyant
among subjects with lower hepatic lipase activities. This
may be due to heterogeneity of the study populations or
the presence of impaired glucose tolerance, which might
have masked the effect of the -250G>A polymorphism
on lipid and lipoprotein levels. Because it is currently
Table 4 Correlative factors for the lipid paramerers between the Bai Ku Yao and Han populations
Group Lipid Relative factor Regression coefficient Standard error tP
Bai Ku Yao TC Age 0.026 0.007 12.193 0.000
TG Gender -1.357 0.293 21.494 0.000
Body mass index 0.268 0.080 11.084 0.001
HDL-C Age 0.028 0.006 18.742 0.000
Alcohol consumption 0.492 0.110 19.828 0.000
Genotype 0.029 0.009 9.629 0.002
Systolic blood pressure -0.013 0.006 5.312 0.021
LDL-C Age 0.021 0.007 8.440 0.004
ApoAI Age 0.028 0.010 8.562 0.003
Alcohol consumption 1.014 0.176 33.347 0.000
ApoAI/ApoB Cigarette smoking -0.412 0.200 4.237 0.040
Alcohol consumption 1.372 0.204 45.362 0.000
Genotype 0.223 0.067 11.256 0.001
Han Chinese TC Age 0.026 0.006 16.564 0.000
Pulse pressure -0.025 0.009 7.525 0.006
TG Cigarette smoking 0.712 0.143 24.861 0.000
Physical activity -0.412 0.161 6.558 0.010
HDL-C Gender 0.666 0.237 7.925 0.005
Age 0.014 0.006 5.674 0.017
Cigarette smoking -0.515 0.163 9.955 0.002
Physical activity 0.786 0.145 29.495 0.000
Body mass index -0.081 0.029 7.995 0.005
Genotype 0.412 0.210 3.899 0.048
LDL-C Age 0.025 0.007 14.006 0.000
Alcohol consumption -0.685 0.201 11.556 0.001
Pulse pressure -0.026 0.009 7.486 0.006
ApoAI Gender 0.656 0.291 5.069 0.024
Alcohol consumption 0.762 0.208 13.461 0.000
Physical activity 1.143 0.293 15.193 0.000
Systolic blood pressure 0.016 0.006 5.946 0.015
ApoB Age 0.024 0.010 5.961 0.015
Genotype 0.665 0.245 7.383 0.007
Gender 1.773 0.486 13.303 0.000
Physical activity 0.509 0.256 3.965 0.046
Diastolic blood pressure 0.035 0.015 5.492 0.019
Allele -2.062 0.670 9.474 0.002
ApoAI/ApoB Gender 1.773 0.486 13.303 0.000
Alcohol consumption 0.955 0.279 11.693 0.001
Physical activity 0.509 0.256 3.965 0.046
Diastolic blood pressure 0.035 0.015 5.492 0.019
Allele -2.062 0.670 9.474 0.002
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B; ApoAI/ApoB, the ratio of apolipoprotein AI to apolipoprotein B.
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functionally important and what are possible mechan-
isms of its action, it is possible that other polymorphism
(s), which are in linkage disequilibrium with the LIPC
promoter polymorphisms, in the same gene or/and
another gene are responsible for the development of
dyslipidaemia.
In addition to gene polymorphisms, a number of other
factors such as demographics [11], diet [12], alcohol
consumption [13], cigarette smoking [13,14], obesity
[15], exercise [16], hypertension [17] modulate plasma
lipid levels. These factors might partly explain why the
association between HDL-C concentration and the
-250G>A polymorphism was not observed in several
previous studies. For example, heavy smokers have, on
average, 9% lower HDL-C levels than matched nonsmo-
kers [14]. Obesity is one of the most important factors
in reducing HDL-C levels [15,55]. Evidences of associa-
tion in different populations with different lifestyles and
diet might suggest that the associations found are robust
to a large number of genetic and environmental factors.
In the present study, we found that many confounding
factors affect serum lipid levels. Serum lipid parameters
were correlated with age, sex, alcohol consumption,
cigarette smoking, BMI, blood pressure and physical
activity. These findings suggest that the environmental
factors also play an important role in determing the
lipid levels in these populations. Differences in the lipid
levels between the two ethnic groups could be related to
factors such as differences in the genetic background,
dietary patterns and lifestyle factors. Although Bai Ku
Yao and Han reside in the same region, there were dif-
ferences in their diet and lifestyle that might account for
the observed differences in serum lipid profiles. Corn
was the staple food and rice, soy, buckwheat, sweet
potato, and pumpkin products were the subsidiary foods
in Bai Ku Yao. Approximately 90% of the beverages
were corn wine and rum. The alcohol content is about
15% (v/v). They are also accustomed to drink Hempseed
soup. In contrast, rice was the staple food and corn,
broomcorn, potato, and taro products were the subsidi-
ary foods in Han. About 90% of the beverage was rice
wine. The content of alcohol is about 30% (v/v). The
staple and subsidiary foods are more favorable for lipid
profiles in the Bai Ku Yao diet than in the Han diet.
Corn contains abundant dietary fiber and plant protein.
Dietary fiber can decrease serum TC levels [56]. Plant
protein can promote the transportation and excretion of
free cholesterol. Soy protein intake is effective in redu-
cing TC by 9.3%, LDL-C by 12.9%, and TG by 10.5%
and in increasing HDL-C by 2.4% [57]. Hypocholestero-
lemic activity of buckwheat protein product is far stron-
ger than that of soy protein isolate [58]. Ludvik and his
colleagues [59] found that ingestion of 4 g/day caiapo
(the extract of white-skinned sweet potato) for 6 weeks
reduces TC and LDL-C in type 2 diabetic patients pre-
viously treated by diet alone. Studies have demonstrated
that pumpkin is a useful therapy for hypercholesterole-
mia through reducing oxidative stress and cholesterol
levels [60]. A number of experimental and clinical stu-
dies have demonstrated that the beneficial effects of
Hempseed or Hempseed oil on lipid profiles include:
decreasing TC, TG and LDL-C levels [60,61], inhibiting
lipid peroxidation [61], reducing atherogenic index [62],
and increasing HDL-C levels [61,62].
In summary, our findings show that there was signifi-
cant difference in genotypic and allelic frequencies of
the LIPC-250G>A polymorphism between the Bai Ku
Yao and Han populations. The levels of HDL-C and
the ratio of ApoAI to ApoB in Bai Ku Yao, and the
levels of TC, HDL-C, LDL-C and ApoB in Han were
influenced by genotype and/or allele. The differences in
the lipid profiles between the two ethnic groups might
partly result from different genotypic frequency
of LIPC -250G>A or different LIPC-enviromental
interactions.
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